Epilepsy: Asia versus Africa

Epilepsia

Volumn 55, Issue 9, 2014, Pages 1317-1321

  Bhalla, Devender ^a,b   Tchalla, Achille Edem ^b,c   Marin, Benoît ^a,d   Ngoungou, Edgard Brice ^a,e   Tan, Chong Tin ^f   Preux, Pierre Marie ^a,d  

^a UNIVERSITÉ DE LIMOGES   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE LIMOGES   (France)

^d LIMOGES UNIVERSITY HOSPITAL   (France)

^e Department of Chemistry and Biochemistry   (Gabon)

^f UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Africa; Asia; Epidemiology; Epilepsy; Incidence; Prevalence

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AFRICAN; ARTICLE; ASIA; ASIAN; BIRTH; CONSANGUINITY; CYSTICERCOSIS; DEMENTIA; EPILEPSY; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE MODIFICATION; MALARIA; MIGRAINE; PREGNANCY; PREMATURE MORTALITY; RISK FACTOR; SUICIDE ATTEMPT; TRAUMATIC BRAIN INJURY; TUBERCULOSIS; DEVELOPING COUNTRY; ECONOMICS; EPIDEMIOLOGY; INCIDENCE; PREVALENCE;

AFRICA; ASIA; EPIDEMIOLOGY; EPILEPSY; INCIDENCE; PREVALENCE;

AFRICA; ASIA; DEVELOPING COUNTRIES; EPILEPSY; HUMANS; RISK FACTORS;

EID: 84908024745     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12629     Document Type: Article

References (59)

1. WHO. Epilepsy in the WHO African region: bridging the gap. Geneva, Switzerland: WHO; 2004.
2. Mac TL, Tran DS, Quet F, et al. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 2007;6:533-543.
3. Preux PM, Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005;4:21-31.
4. Benamer HT, Grosset DG. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia 2009;50:2301-2304.
5. WHO. The world health report 2006: working together for health. Geneva, Switzerland: WHO; 2006a.
6. WHO. Epilepsy in the south-east Asia region- bridging the gap. Geneva, Switzerland: WHO; 2005.
7. United Nations. Changing levels and trends in mortality: the role of patterns of death by cause. New York, NY, USA: Department of Economic and Social Affairs; 2012.
8. UN. World population prospects: the 2006 revision. New York: United Nations; 2006.
9. Chin J. Epilepsy treatment in sub-Saharan Africa: closing the gap. Afr Health Sci 2012;12:186-192.
10. Mbuba CK, Ngugi AK, Newton CR, et al. The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008;49:1491-1503.
11. WHO. Atlas: epilepsy care in the world. Geneva, Switzerland: WHO; 2005.
12. Lim KS, Lim CH, Tan CT. Attitudes toward epilepsy, a systematic review. Neurology Asia 2011;16:269-280.
13. Burneo JG, Tellez-Zenteno J, Wiebe S. Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res 2005;66:63-74.
14. Masri A, Badran E, Hamamy H, et al. Etiologies, outcomes, and risk factors for epilepsy in infants: a case-control study. Clin Neurol Neurosurg 2008;110:352-356.
15. Saadat M. Consanguinity associated with child and adult mortality in 24 Asian and African countries, an ecological study. Iran J Public Health 2007;36:35-39.
16. Bhalla D, Chea K, Hun C, et al. Population-based study of epilepsy in Cambodia associated factors, measures of impact, stigma, quality of life, knowledge-attitude-practice, and treatment gap. PLoS ONE 2012;7:1-9.
17. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-2172.
18. Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010;88:31-38.
19. Bolte A, Steinmann HW, Beusch CH, et al. Childhood brain lesions after operative delivery. Catamnestic and electroencephalographic studies after forceps delivery, vacuum extraction, breech presentation and abdominal cesearean section. Arch Gynakol 1968; 205:110-150.
20. Ehrenstein V, Pedersen L, Holsteen V, et al. Postterm delivery and risk for epilepsy in childhood. Pediatrics 2007;119:e554-e561.
21. Dumont A, de Bernis L, Bouvier-Colle MH, et al. Caesarean section rate for maternal indication in sub-Saharan Africa: a systematic review. Lancet 2001;358:1328-1333.
22. Lumbiganon P, Laopaiboon M, Gulmezoglu AM, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08. Lancet 2010;375:490-499.
23. Festin MR, Laopaiboon M, Pattanittum P, et al. Caesarean section in four South East Asian countries: reasons for, rates, associated care practices and health outcomes. BMC Pregnancy Childbirth 2009;9:17.
24. Bhalla D, Godet B, Druet-Cabanac M, et al. Etiologies of epilepsy: a comprehensive review. Expert Rev Neurother 2011;11:861-876.
25. Hyder AA, Wunderlich CA, Puvanachandra P, et al. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 2007;22:341-353.
26. WHO. World health report 2002: comparative quantification of health risks. Geneva, Switzerland: World Health Organization; 2002.
27. Chandran A, Hyder AA, Peek-Asa C. The global burden of unintentional injuries and an agenda for progress. Epidemiol Rev 2010;32:110-120.
28. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 1999;15:365-375.
29. ADI. The prevalence of dementia worldwide. London, UK: Alzheimer's Disease International; 2008.
30. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-2117.
31. WHO. Atlas of headache disorders and resources in the world. Geneva, Switzerland: WHO; 2011.
32. Ludvigsson P, Hesdorffer D, Olafsson E, et al. Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol 2006;59:210-213.
33. Varnik P. Suicide in the world. Int J Environ Res Public Health 2012;9:760-771.
34. Vijayakumar L. Suicide prevention: the urgent need in developing countries. World Psychiatry 2004;3:158-159.
35. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006;59:35-41.
36. WHO. Global tuberculosis report. Geneva, Switzerland: WHO; 2012.
37. WHO. Global tuberculosis control 2011. Geneva, Switzerland: World Health Organization; 2011.
38. WHO. Progress on global access to HIV antiretroviral therapy: a report on 3 by 5 and beyond. Geneva, Switzerland: WHO; 2006b.
39. Sinha S, Satishchandra P, Nalini A, et al. New-onset seizures among HIV infected drug naive patients from south India. Neurology Asia 2005;10:29-33.
40. Trinka E, Dubeau F, Andermann F, et al. Clinical findings, imaging characteristics and outcome in catastrophic post-encephalitic epilepsy. Epileptic Disord 2000;2:153-162.
41. Nicoll AR, Maitland NJ, Love S. Autopsy neuropathological findings in "burnt out" Herpes simplex encephalitis and the use of polymerase chain reaction to detect viral DNA. Neuropathol Appl Neurobiol 1991;17:375-382.
42. Eeg-Olofsson O, Bergstrom T, Osterland CK, et al. Epilepsy etiology with special emphasis on immune dysfunction and neurovirology. Brain Dev 1995;17(Suppl.):58-60.
43. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia 2008;49(Suppl. 6):13-18.
44. Singh B, Kim Sung L, Matusop A, et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 2004;363:1017-1024.
45. Ngoungou EB, Preux PM. Cerebral malaria and epilepsy. Epilepsia 2008;49(Suppl. 6):19-24.
46. Rajshekhar V, Joshi DD, Doanh NQ, et al. Taenia solium taeniosis/ cysticercosis in Asia: epidemiology, impact and issues. Acta Trop 2003;87:53-60.
47. Ito A, Nakao M, Wandra T. Human Taeniasis and cysticercosis in Asia. Lancet 2003;362:1918-1920.
48. Simanjuntak GM, Margono SS, Okamoto M, et al. Taeniasis/ cysticercosis in Indonesia as an emerging disease. Parasitol Today 1997;13:321-323.
49. Sutisna P, Fraser A, Kapti I. Community prevalence study of taeniasis and cysticercosis in Bali, Indonesia. Trop Med Int Health 1999;4:288-294.
50. Singh G. Neurocysticercosos in South-Central America and the Indian subcontinent. A comparative evaluation. Arq Neuropsiquiatr 1997;55:349-356.
51. Sharma LN, Garg RK, Verma R, et al. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebral calcification: a comparative evaluation. Seizure 2013;22:840-845.
52. Pradhan S, Yadav R. Seizures and epilepsy in central nervous system infections. Neurology Asia 2004;9:4-9.
53. Singh TS, Sugiyama H, Rangsiruji A. Paragonimus & paragonimiasis in India. Indian J Med Res 2012;136:192-204.
54. Nawa Y. Re-emergence of paragonimiasis. Intern Med 2000;39:353-354.
55. Aka NA, Adoubryn K, Rondelaud D, et al. Human paragonimiasis in Africa. Ann Afr Med 2008;7:153-162.
56. Chen J, Chen Z, Lin J, et al. Cerebral paragonimiasis: a retrospective analysis of 89 cases. Clin Neurol Neurosurg 2013;115: 546-551.
57. Lo MK, Lowe L, Hummel KB, et al. Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010. Emerg Infect Dis 2012;18:248-255.
58. Field H, Young P, Yob JM, et al. The natural history of Hendra and Nipah viruses. Microbes Infect 2001;3:307-314.
59. Chisholm D, Saxena S. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ 2012;344:e609.